Estimates of the prevalence of autism spectrum disorder in the Middle East and North Africa region: A systematic review and Meta-Analysis
- PMID: 40691829
- PMCID: PMC12278510
- DOI: 10.1186/s12889-025-23651-x
Estimates of the prevalence of autism spectrum disorder in the Middle East and North Africa region: A systematic review and Meta-Analysis
Abstract
Background: Prevalence estimates for autism spectrum disorder (ASD) in the Middle East and North Africa (MENA) region are not readily available, amid a lack of recent evidence. In this study, we estimated the prevalence of ASD in the MENA region by synthesising evidence from published studies.
Methods: We conducted a systematic review and meta-analysis, searching PubMed, EMBASE, Scopus, and CINAHL for studies assessing ASD prevalence in the MENA region. Risk of bias was assessed using the Newcastle Ottawa scale. A bias-adjusted inverse variance heterogeneity meta-analysis model was used to synthesize prevalence estimates from included studies. Cochran's Q statistic and the I2 statistic were used to assess heterogeneity, and publication bias assessed using funnel and Doi plots.
Results: Of 3,739 studies identified, 19 met the inclusion criteria, published during the period 2007-2025, from Iran, Oman, Libya, Egypt, Saudi Arabia, Lebanon, United Arab Emirates, Bahrain, and Qatar, Iraq. Country specific prevalence estimates ranged from 0.01% in Oman in 2009 to 6.50% in one study from Iraq in 2024. The overall prevalence of ASD in the MENA region was 0.14% (95%CI 0.02- 0.36%), with significant heterogeneity (I2 = 99.8%). Overall ASD prevalence was 0.04% (95%CI 0.00-0.13, I2 = 99.4%) for studies done before 2015 and 0.45% (95%CI 0.17-0.87, I2 = 99.4%) for studies after 2015. Overall ASD prevalence was high in studies that used the Modified Checklist for Autism in Toddlers (M-CHAT) only [1.66% (95%CI 0.15-4.33, I2 = 97.5%)] while the overall ASD prevalence was 0.14% (95%CI 0.00-0.46, I2 = 99.9%) for studies that used the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for diagnosis.
Conclusion: Estimates of the prevalence of ASD vary widely across the MENA region, with variability in ASD prevalence estimates by diagnostic methods and sampling approaches. While the data suggest a possible increase in prevalence during the study period, this observation warrants further investigation through more robust, longitudinal, and methodologically consistent studies.
Registration: PROSPERO registration ID CRD42024499837.
Keywords: Autism spectrum disorder; Middle East and North Africa; Prevalence.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This review used secondary data from peer-reviewed published studies and does not require ethical clearance or consent to participate. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests.
Figures






Similar articles
-
Prevalence of Latent Tuberculosis Infection in the Middle East and North Africa: A Systematic Review.Pulm Med. 2021 Jan 28;2021:6680651. doi: 10.1155/2021/6680651. eCollection 2021. Pulm Med. 2021. PMID: 33564476 Free PMC article.
-
Nutritional Status and Feeding Behavior of Children with Autism Spectrum Disorder in the Middle East and North Africa Region: A Systematic Review.Nutrients. 2023 Jan 30;15(3):711. doi: 10.3390/nu15030711. Nutrients. 2023. PMID: 36771417 Free PMC article.
-
Long-term Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in the Middle East and North Africa: a Systematic Review and Meta-analysis of 178 Population-Based Studies.Curr Hypertens Rep. 2021 Oct 8;23(9):41. doi: 10.1007/s11906-021-01159-0. Curr Hypertens Rep. 2021. PMID: 34625888
-
Aripiprazole for autism spectrum disorders (ASD).Cochrane Database Syst Rev. 2016 Jun 26;2016(6):CD009043. doi: 10.1002/14651858.CD009043.pub3. Cochrane Database Syst Rev. 2016. PMID: 27344135 Free PMC article.
-
Methylphenidate for children and adolescents with autism spectrum disorder.Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2. Cochrane Database Syst Rev. 2017. PMID: 29159857 Free PMC article.
References
-
- Association AP. Diagnostic and statistical manual of mental disorders: DSM-5. American psychiatric association; 2013.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous